News

The first approved COVID-19 drug is far from ‘amazing’

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, The coronavirus pandemic is overwhelming the US yet again, with the country recording its 2 worst-ever days of infection […]
The first approved COVID-19 drug is far from ‘amazing’
News

Trump’s doctors are targeting a ‘sweet spot’ in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited

President Donald Trump is taking several drugs to combat COVID-19, a combination approach that critical care doctors called rational but untested. Over the past few days, the president confirmed his diagnosis, was injected with an experimental antibody cocktail, transported to Walter Reed Medical Centre, and given an IV infusion of […]
Trump’s doctors are targeting a ‘sweet spot’ in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited
Markets

US stocks fluctuate as traders weigh virus spike against advances in treatment

US stocks fluctuated as traders weighed another record spike in virus cases against advances in treatment. On Thursday the US reported 63,200 new coronavirus cases, another record spike, according to data from Johns Hopkins University Meanwhile, Gilead Sciences released clinical-trial data on Friday suggesting its remdesivir treatment reduced COVID-19 mortality […]
US stocks fluctuate as traders weigh virus spike against advances in treatment
News

The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir

After months of anticipation, Gilead announced Monday the price of remdesivir, the first effective coronavirus treatment. The California drugmaker will charge governments of developed countries, including the US, $US2,340 for a five-day treatment course. US private insurers will pay 33% more, or $US3,120 for the standard five-day treatment course. Hospitalized […]
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir
Markets

Gilead rises after pricing its coronavirus-fighting drug remdesivir

Gilead Sciences on Monday disclosed its pricing for remdesivir, its coronavirus-fighting drug. Shares of the company jumped as much as 4% in premarket trading. The company will charge the US government and developed countries $US390 per vial of remdesivir, or $US2,340 for a five-day course using six vials of the […]
Gilead rises after pricing its coronavirus-fighting drug remdesivir
News

The UK drugs giant AstraZeneca wants its US rival Gilead to consider a merger

AstraZeneca approached Gilead and asked it to consider a merger, according to Bloomberg. Citing sources familiar with the matter, Bloomberg said the contact happened in May but AstraZeneca “didn’t specify terms for any transaction.” A source told the news outlet that Gilead is not currently interested in merging with another […]
The UK drugs giant AstraZeneca wants its US rival Gilead to consider a merger
News

US health authorities will allow emergency use of Gilead’s coronavirus treatment

The US Food and Drug Administration will allow emergency use of Gilead’s coronavirus treatment remdesivir. Remdesivir helped coronavirus patients recover 31% faster than those taking a placebo, the US National Institutes of Health said Wednesday. The move allows for broader use of remdesivir. However an emergency use authorization is not […]
US health authorities will allow emergency use of Gilead’s coronavirus treatment
News

US health authorities are reportedly preparing to allow emergency use of Gilead’s antiviral remdesivir to treat coronavirus patients, following positive study results

US health regulators are planning to authorise the emergency use of an experimental coronavirus treatment as soon as today, the New York Times reported. The US Food and Drug Administration is currently planning the announcement, the NYT reported, citing a senior administration official. In a statement to Business Insider, FDA […]
US health authorities are reportedly preparing to allow emergency use of Gilead’s antiviral remdesivir to treat coronavirus patients, following positive study results